首页> 外文期刊>Clinical cardiology. >Impact of Diabetes Mellitus on the Clinical Management of Global Cardiovascular Risk: Analysis of the Results of the Evaluation of Final Feasible Effect of Control Training and Ultra Sensitization (EFFECTUS) Educational Program
【24h】

Impact of Diabetes Mellitus on the Clinical Management of Global Cardiovascular Risk: Analysis of the Results of the Evaluation of Final Feasible Effect of Control Training and Ultra Sensitization (EFFECTUS) Educational Program

机译:糖尿病对全球心血管疾病临床管理的影响:对照训练和超敏化(EFFECTUS)教育计划最终可行效果评估结果分析

获取原文
           

摘要

Background:The Evaluation of Final Feasible Effect of Ultra Control Training and Sensitization (EFFECTUS) study is aimed at implementing global cardiovascular (CV) risk management in Italy.Hypothesis:To evaluate the impact of diabetes mellitus (DM) on attitudes and preferences for clinical management of global CV risk among physicians treating diabetic or nondiabetic patients.Methods:Involved physicians were asked to submit data into a study-designed case-report form, covering the first 10 adult outpatients consecutively seen in May 2006. All available clinical data were centrally analyzed for global CV risk assessment and CV risk profile characterization. Patients were stratified according to the presence or absence of DM.Results:Overall, 1078 physicians (27% female, ages 50 ± 7 y) collected data of 9904 outpatients (46.5% female, ages 67 ± 9 y), among whom 3681 (37%) had a diagnosis of DM at baseline. Diabetic patients were older and had higher prevalence of obesity, hypertension, dyslipidemia, and associated CV diseases than nondiabetic individuals (P0.001). They had higher systolic blood pressure, total cholesterol, triglycerides, and creatinine levels, but lower high-density lipoprotein cholesterol levels than nondiabetic patients (P0.001). Higher numbers of blood pressure and lipid-lowering drugs and antiplatelet agents were used in diabetic than in nondiabetic patients (P0.001).Conclusions:The EFFECTUS study confirmed higher CV risk and more CV drug prescriptions in diabetic than in nondiabetic patients. Presence of DM at baseline significantly improved clinical data collection. Such an approach, however, was not paralleled by a better control of global CV risk profile, which was significantly worse in the former than in the latter group. ? 2011 Wiley Periodicals, Inc.This work has been supported by an unconditioned educational grant by Merck Sharp & Dohme, Italy, for data collection and analysis. The authors have no other funding, financial relationships, or conflicts of interest to disclose.
机译:背景:对超控制训练和敏化作用(EFFECTUS)的最终可行效果的评估旨在在意大利实施全球心血管(CV)风险管理。假设:评估糖尿病(DM)对临床态度和偏好的影响方法:要求涉及的医师将数据提交研究设计的病例报告表,涵盖2006年5月连续观察的前10名成人门诊患者。所有可用的临床数据均集中于中央分析以进行全球简历风险评估和简历风险概况表征。结果:总体上,共有1078位医生(女性占27%,年龄50±7岁)的1078名医师(女性占46.5%,年龄67±9岁)的数据被收集,其中3,681位(女性)。 37%)在基线时诊断为DM。与非糖尿病患者相比,糖尿病患者年龄更大,肥胖,高血压,血脂异常和相关的心血管疾病患病率更高(P <0.001)。与非糖尿病患者相比,他们的收缩压较高,总胆固醇,甘油三酸酯和肌酐水平较高,但高密度脂蛋白胆固醇水平较低(P <0.001)。与非糖尿病患者相比,糖尿病患者使用的降血压,降脂药和抗血小板药物的数量更高(P <0.001)。结论:EFFECTUS研究证实,与非糖尿病患者相比,糖尿病患者的心血管风险和处方药处方更高。基线存在DM可显着改善临床数据收集。但是,这种方法并不能更好地控制全球CV风险状况,前者比后者更差。 ? 2011年Wiley Periodicals,Inc.这项工作得到了意大利默克·夏普(Merck Sharp&Dohme)的无条件教育补助金的支持,用于数据收集和分析。作者没有其他资金,财务关系或利益冲突需要披露。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号